Pandemic-related resilience in HPV vaccination programmes – Perspectives from selected countries in Africa on what it will take to vaccinate 90% of girls by 2030

In this series of five country case studies, Kouassi and colleagues document how Côte d’Ivoire, Kenya, Liberia, Zambia, and Senegal maintained and recovered their HPV vaccination programmes following COVID-19 disruptions. Common challenges included school closures, misinformation conflating HPV and COVID-19 vaccines, and competing health priorities that diverted staff and funding. Enabling factors included strong Ministry […]

Africa Hpv Roadshow: Accelerating HPV Vaccination Demand Post Covid-19 Pandemic

This poster describes a regional initiative to reignite HPV vaccine demand in sub-Saharan Africa following the COVID-19 pandemic. The project brought together 78 key stakeholders from 14 countries through cohort-based workshops to share experiences and co-develop country-specific roadmaps. Key challenges identified include budget constraints, data quality gaps, and misconceptions about the vaccine. The initiative promotes […]

HPV Vaccine delivery strategies Kenya

Cette présentation décrit l’expérience du Kenya dans la mise en œuvre de la vaccination contre le HPV, depuis la phase de démonstration jusqu’au déploiement national. Un projet pilote mené dans le comté de Kitui entre 2013 et 2015, basé sur les écoles, a montré une forte acceptabilité et une couverture de plus de 85 %, […]

HPV Vaccine Delivery – Liberia

Liberia’s experience with HPV vaccine delivery began with a demonstration project in 2016, targeting 10-year-old girls in Bong and Nimba counties through a “learning by doing” approach. The demonstration was followed by a post-introduction evaluation (PIE) and a coverage survey. Based on the success and insights gained, the HPV vaccine was integrated into the national […]

Introduction during Covid-19: implications and strategies to tackle interruptions. The case of Cameroon

This presentation from Cameroon outlined the challenges and strategies for HPV vaccine delivery during the COVID-19 pandemic. The vaccine was introduced into the routine immunization schedule in October 2020, targeting 9-year-old girls. However, early rollout faced significant barriers: insecurity in three regions, low community awareness, widespread misinformation, limited communication, and strong resistance from some religious […]

HPV Vaccine delivery strategies Kenya

This presentation outlines Kenya’s experience with HPV vaccine delivery, from demonstration to national rollout. A demonstration project conducted in Kitui County between 2013 and 2015 through a school-based program achieved high acceptability and over 85% coverage, but the delivery cost was high. These findings informed Kenya’s decision to introduce HPV vaccination into its routine immunization […]

Discussion on delivery strategies: Are school based programs sustainable? How HPV vaccine delivery platforms can be made sustainable?

The closing panel explored how to sustain and adapt HPV vaccination programs, especially in the aftermath of COVID-19. Countries shared challenges in reaching out-of-school girls, mobile populations, and those changing schools—prompting shifts like Zambia’s decision to target 9-year-olds for greater stability. Consent requirements in private schools were seen as a barrier, highlighting the need for […]

>